Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus
- PMID: 3878482
- DOI: 10.1016/0304-3940(85)90424-0
Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus
Abstract
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces a profound parkinsonian state when systemically administered in monkeys and man. Previous studies have shown MPTP to be toxic to only the dopamine (DA) cells in the substantia nigra pars compacta and not to other catecholamine (CA)-containing cells. The data presented here suggest that MPTP also has a specific neurotoxic effect on the DA-containing cells of the ventral tegmental area and the noradrenaline-containing cells of the locus coeruleus in macaque monkeys with a moderate-to-severe parkinsonian syndrome. The results suggest that MPTP-induced parkinsonism in the monkey more closely replicates the neurochemical changes seen in idiopathic Parkinson's disease than previously thought.
Similar articles
-
Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP.Brain Res. 1987 May 12;411(1):144-50. doi: 10.1016/0006-8993(87)90691-3. Brain Res. 1987. PMID: 2886180
-
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?Neuroscience. 1988 Jan;24(1):161-74. doi: 10.1016/0306-4522(88)90320-x. Neuroscience. 1988. PMID: 3259295
-
N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the monkey: neurochemical pathology and regional brain metabolism.J Neural Transm Suppl. 1986;20:41-6. J Neural Transm Suppl. 1986. PMID: 3462325
-
[Significance of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine for the etiology and therapy of idiopathic Parkinson disease].Fortschr Neurol Psychiatr. 1989 Apr;57(4):142-8. doi: 10.1055/s-2007-1000755. Fortschr Neurol Psychiatr. 1989. PMID: 2656447 Review. German.
-
MPTP-induced parkinsonism in the monkey: neurochemical pathology, complications of treatment and pathophysiological mechanisms.Can J Neurol Sci. 1987 Aug;14(3 Suppl):428-35. doi: 10.1017/s0317167100037859. Can J Neurol Sci. 1987. PMID: 3119180 Review.
Cited by
-
Clues to the mechanism underlying dopamine cell death in Parkinson's disease.J Neurol Neurosurg Psychiatry. 1989 Jun;Suppl(Suppl):22-8. doi: 10.1136/jnnp.52.suppl.22. J Neurol Neurosurg Psychiatry. 1989. PMID: 2666576 Free PMC article. Review.
-
The use of thalamotomy in the treatment of levodopa-induced dyskinesia.Acta Neurochir (Wien). 1992;114(3-4):77-117. doi: 10.1007/BF01400598. Acta Neurochir (Wien). 1992. PMID: 1580197 Review.
-
Behavioural effects of (+)-4-propyl-9-hydroxynaphthoxazine in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.Naunyn Schmiedebergs Arch Pharmacol. 1988 Jul;338(1):35-8. doi: 10.1007/BF00168809. Naunyn Schmiedebergs Arch Pharmacol. 1988. PMID: 2907097
-
Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.Br J Pharmacol. 2011 Oct;164(4):1357-91. doi: 10.1111/j.1476-5381.2011.01426.x. Br J Pharmacol. 2011. PMID: 21486284 Free PMC article. Review.
-
Animal models of Parkinson's disease: a guide to selecting the optimal model for your research.Neuronal Signal. 2021 Dec 8;5(4):NS20210026. doi: 10.1042/NS20210026. eCollection 2021 Dec. Neuronal Signal. 2021. PMID: 34956652 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous